OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
原文:https://www.a8q9.cn/en/article/openai-acquires-orchestra-bio-fd2a3a.html